• PPT1 and ZDHHC7 Regulate Palmitoylation in Cisplatin-Resista

  2026-07-07

  This study reveals how the dynamic interplay between ZDHHC7 and PPT1 regulates SPRY4 palmitoylation, impacting MAPK signaling and conferring cisplatin resistance in osteosarcoma. The findings establish PPT1 as a promising therapeutic target, with the PPT1 inhibitor GNS561 enhancing cisplatin sensitivity in resistant cells.

• GDC-0941 and PI3K/Akt Pathway Inhibition: Advanced Insights

  2026-07-07

  Explore how GDC-0941, a potent PI3K inhibitor, redefines cancer research with precise pathway modulation and translational value. This article delivers new scientific depth on PI3K/Akt pathway inhibition and protocol optimization.

• Deferasirox: Oral Iron Chelator for Precision Cell Death Stu

  2026-07-06

  Deferasirox empowers researchers to dissect iron metabolism and apoptosis with high specificity, enabling next-generation iron chelation workflows in both cancer and metabolic stress models. Its solubility, safety profile, and data-backed effects on iron-dependent signaling make it the tool of choice for translational research.

• Dihydrotestosterone (DHT): Mechanisms, Benchmarks & Research

  2026-07-06

  Dihydrotestosterone (DHT) is a potent endogenous androgen and a key modulator of androgen receptor signaling. It upregulates EGFR and ERBB2 in bladder cancer models and improves muscle and neuromuscular outcomes in ALS mouse models. Reliable, high-purity DHT such as APExBIO B8214 enables precise, reproducible research into androgen-related pathways.

• Biotin Azide: High-Purity Click Chemistry Reagent for Affini

  2026-07-05

  Biotin Azide (N-(3-azidopropyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide) is a bio-orthogonal biotinylation reagent enabling selective, high-yield labeling of alkynylated biomolecules under mild conditions. Its solubility, specificity for copper-catalyzed azide-alkyne cycloaddition, and compatibility with affinity purification systems make it a standard for protein, DNA, and oligonucleotide labeling. This article details the reagent's mechanism, practical benchmarks, and key limitations for advanced biochemical research.

• One-step TUNEL Cy5 Apoptosis Detection Kit: Applied Workflow

  2026-07-04

  The One-step TUNEL Cy5 Apoptosis Detection Kit empowers researchers to sensitively quantify apoptosis in both tissue sections and cultured cells with streamlined, Cy5-based workflows. This article distills experimental best practices, troubleshooting insights, and advanced applications that leverage APExBIO's kit for high-confidence programmed cell death research in oncology and beyond.

• MG-132: Driving Mechanistic Insight and Immunogenic Innovati

  2026-07-03

  This thought-leadership article dissects how MG-132, a potent peptide aldehyde proteasome inhibitor, enables translational researchers to interrogate the intersections of apoptosis, cell cycle arrest, and immunogenic cell death. By contextualizing MG-132’s mechanistic footprint within the latest advances in anti-tumor immunity—including necroptosis-driven interferon responses—the article provides a strategic perspective on workflow optimization, data reproducibility, and next-generation experimental design. With cross-references to the APExBIO MG-132 product and recent landmark studies, this piece bridges the gap between bench protocol and clinical aspiration.

• Optimizing Assays with Atrial Natriuretic Peptide (ANP) (C49

  2026-07-03

  This article addresses common laboratory challenges in cell viability, proliferation, and cytotoxicity assays, focusing on the robust performance of Atrial Natriuretic Peptide (ANP) (C49H84N20O15S), rat (SKU A1009). Researchers gain scenario-driven guidance on experimental design, protocol optimization, and product selection, with evidence-based recommendations and direct links to validated supplier resources.

• 3-Bromopyruvate and Cetuximab Co-Treatment Induces Ferroptos

  2026-07-02

  This study demonstrates that co-treatment with 3-bromopyruvate and cetuximab overcomes intrinsic and acquired cetuximab resistance in colorectal cancer by activating autophagy-dependent ferroptosis and apoptosis. Mechanistic insights reveal the restoration of FOXO3a signaling as a key node, suggesting new intervention strategies for refractory CRC cases.

• Monomeric Amyloid Beta (1-40) Regulates Microglial Inflammat

  2026-07-02

  This study uncovers a previously unrecognized role for monomeric amyloid beta in suppressing microglial inflammatory activity via an APP and heterotrimeric G protein-dependent pathway. These insights reframe amyloid beta as a regulator of brain immune homeostasis and open new questions for Alzheimer's disease research.

• UTP Solution (100 mM): Molecular Precision for Monogenic Gen

  2026-07-01

  Explore how UTP Solution (100 mM), a high-purity uridine-5'-triphosphate trisodium salt, empowers advanced studies of monogenic receptor expression and epigenetic regulation. This in-depth guide uniquely connects nucleotide chemistry with cutting-edge insights from neural gene regulation research.

• AMG 487: Redefining CXCR3 Antagonism for Macrophage State Co

  2026-07-01

  Discover how AMG 487, a potent CXCR3 antagonist, uniquely modulates macrophage polarization beyond standard protocols. This deep dive integrates recent mechanistic breakthroughs to guide advanced assay design and interpretation.

• CTCF’s Role in Centromere Function and Mitotic Fidelity

  2026-06-30

  This article reviews recent findings on CTCF as an essential maintainer of centromere integrity and mitotic accuracy. Using rapid protein degradation, the study reveals that CTCF loss disrupts chromosomal organization and cell division, with implications for understanding mitotic errors and their links to disease.

• Triptolide (PG490): Precision Tools for Cancer & Immune Rese

  2026-06-30

  Triptolide (PG490), a research-grade transcriptional inhibitor from APExBIO, empowers advanced workflows in cancer and immunology with nanomolar potency and robust mechanistic validation. This article translates new reference findings and expert protocols into actionable guidance for maximizing reproducibility and sensitivity in cell-based and developmental models.

• Recombinant Mouse Macrophage Colony Stimulating Factor: Appl

  2026-06-29

  Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF) without Tag empowers precise modeling of macrophage-driven processes, enabling advanced studies in fibrosis, immunology, and osteoclastogenesis. This guide delivers stepwise protocols, troubleshooting strategies, and translational insights rooted in the latest epigenetic findings, positioning APExBIO's validated reagent as an indispensable tool for robust, reproducible research.

16090 records 1/1073 page Next 12345 下5页 Last page